Canopus BioPharma Incorporated (CBIA)

OTC • Currency in USD

$0.00

0.00%

Last Update: 2 Jul 2025, 20:00

$455.07K

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

$0.00 - $0.00

52 Week Range

CBIA Stock Price Chart

Explore Canopus BioPharma Incorporated interactive price chart. Choose custom timeframes to analyze CBIA price movements and trends.

There is nothing to show.

CBIA Company Profile

Discover essential business fundamentals and corporate details for Canopus BioPharma Incorporated (CBIA) to support your stock research and investment decisions.

Sector

Financial Services

Industry

Shell Companies

IPO Date

31 Dec 1999

Employees

—

Website

https://www.blueheaven.cafe

CEO

Patrick T. Prendergast

Description

Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.

CBIA Financial Timeline

Browse a chronological timeline of Canopus BioPharma Incorporated corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

CBIA Stock Performance

Access detailed CBIA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.